|
Market Closed -
Nasdaq
01:00:00 17/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 122.88 USD | +1.42% |
|
+5.84% | -29.40% |
| 11-16 | Insmed Incorporated Presents at Jefferies Global Healthcare Conference 2026, Nov-16-2026 02:00 PM | |
| 11-02 | Mizuho Adjusts Price Target on Insmed to $158 From $154, Keeps Outperform Rating | MT |
| Market Cap | 26.96B 24.49B 22.63B 20.44B 38.57B 2,531B 39.93B 272B 108B 1,358B 101B 99.01B 4,303B | P/E 2026 * |
-75x | P/E 2027 * | 172x |
|---|---|---|---|---|---|
| Enterprise Value | 26.44B 24.02B 22.2B 20.05B 37.84B 2,483B 39.17B 267B 106B 1,332B 99.22B 97.13B 4,221B | EV / Sales 2026 * |
14.2x | EV / Sales 2027 * | 8.69x |
| Free-Float |
98.99% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INSM | Delayed | |
| INSM | Real-time | ||
| INSM * | End-of-day quote | ||
| IM8N | Real-time | ||
| IM8N | Delayed | ||
| IM8N | End-of-day quote | ||
| IM8N | Real-time | ||
| IM8N | Delayed | ||
| 1INSM | End-of-day quote | ||
| IM8N | Delayed |
Last Transcript: Insmed Incorporated
| 1 day | +1.42% | ||
| 1 week | +5.84% | ||
| Current month | +9.15% | ||
| 1 month | +27.64% | ||
| 3 months | -0.70% | ||
| 6 months | +12.59% | ||
| Current year | -29.40% |
| 1 week | 116.89 | 124.92 | |
| 1 month | 92.62 | 124.92 | |
| Current year | 90.39 | 186.19 | |
| 1 year | 90.39 | 212.75 | |
| 3 years | 21.92 | 212.75 | |
| 5 years | 16.04 | 212.75 | |
| 10 years | 11.31 | 212.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 57 | 10/09/2012 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 62 | 19/12/2019 |
Roger Adsett
COO | Chief Operating Officer | 57 | 14/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Melvin Sharoky
CHM | Chairman | 75 | 16/06/2009 |
Will Lewis
CHM | Chairman | 57 | 08/11/2018 |
David Brennan
BRD | Director/Board Member | 72 | 29/05/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/10/26 | Free | Director | 6,139 | 0.0028% | ||
| 19/10/26 | Free | Director | 6,139 | 0.0028% | ||
| 09/09/26 | Sell | Director | -25,000 | 0.0114% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.42% | +5.84% | -36.40% | +402.78% | 26.96B | ||
| -1.29% | -3.91% | +51.98% | +69.06% | 65.56B | ||
| -3.08% | -1.57% | +7.34% | +88.06% | 60.41B | ||
| -0.91% | +0.67% | +23.36% | +87.44% | 55.76B | ||
| -1.26% | -1.45% | +12.43% | +117.42% | 46.98B | ||
| -0.15% | -5.06% | +20.00% | +29.27% | 43.63B | ||
| +0.23% | +2.14% | +14.85% | +46.22% | 36.7B | ||
| -3.15% | -16.63% | +146.30% | +685.27% | 36.09B | ||
| -2.15% | -3.32% | +75.25% | +56.16% | 32.9B | ||
| -0.94% | -6.69% | +43.08% | -2.01% | 24.45B | ||
| Average | -1.12% | -1.92% | +35.82% | +157.97% | 43B | |
| Weighted average by Cap. | -1.27% | -1.74% | +34.89% | +141.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86B 1.69B 1.56B 1.41B 2.66B 175B 2.76B 18.79B 7.44B 93.79B 6.98B 6.84B 297B | 2.99B 2.72B 2.51B 2.27B 4.28B 281B 4.43B 30.21B 11.97B 151B 11.23B 10.99B 478B |
| Net income | -357M -325M -300M -271M -511M -33.55B -529M -3.61B -1.43B -18.01B -1.34B -1.31B -57.04B | 167M 152M 141M 127M 240M 15.72B 248M 1.69B 670M 8.44B 628M 615M 26.72B |
| Net Debt | -514M -467M -432M -390M -736M -48.31B -762M -5.19B -2.06B -25.92B -1.93B -1.89B -82.11B | -949M -862M -797M -720M -1.36B -89.11B -1.41B -9.58B -3.8B -47.82B -3.56B -3.49B -151B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | $122.88 | +1.42% | 2,233,188 |
| 13/11/26 | $121.16 | +2.62% | 1,543,624 |
| 12/11/26 | $118.07 | -2.22% | 2,397,944 |
| 11/11/26 | $120.75 | +1.05% | 1,488,927 |
| 10/11/26 | $119.49 | +2.92% | 3,346,741 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- INSM Stock
Select your edition
All financial news and data tailored to specific country editions
















